Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
<h4>Background</h4>Cardiovascular disease is a primary cause of death in patients with chronic obstructive pulmonary disease (COPD). Beta-blockers have been proved to reduce morbidity and improve survival in patients with cardiac diseases. But the effects of beta-blockers on outcomes in...
Saved in:
| Main Authors: | Qingxia Du, Yongchang Sun, Ning Ding, Lijin Lu, Ying Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113048&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programme
by: Jennifer K Quint, et al.
Published: (2025-07-01) -
Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
by: Shan-Ju Lin, et al.
Published: (2023-07-01) -
Effect of beta-blockers on mortality in patients with sepsis and septic shock: a systematic review and meta-analysis
by: Paul E. Hernández-Montes, et al.
Published: (2025-07-01) -
Beta-Blockers and mortality in patients with malignancy and cardiovascular disease: an analysis of the MIMIC-IV database
by: Bing-ao Chen, et al.
Published: (2025-08-01) -
Persistent Beta‐Blocker Therapy Reduces Long‐Term Mortality in Patients With Acute Ischemic Stroke With Elevated Heart Rates
by: Keon‐Joo Lee, et al.
Published: (2025-03-01)